Introduction {#s1}
============

Carbapenem, a β-lactam that is highly potent against Gram-negative bacteria, has been recognized as a last resort for treating of infections caused by multidrug-resistant bacteria. However, the increasing number of carbapenem-resistant *Enterobacteriaceae* (CRE) is unexpected despite infection control efforts, and it poses a great challenge to clinic (Zilberberg and Shorr, [@B52]). Carbapenem resistance is predominantly attributed to the presence of carbapenemases, among which Class A (*bla*~KPC~), Class B (*bla*~NDM~*, bla*~VIM~*, bla*~IMP~), and Class D (*bla*~OXA−48~) types are most common for *Enterobacteriaceae* (Walsh, [@B38]; Albiger et al., [@B2]). An emerging carbapenemase, New Delhi metallo-lactamase (NDM), was first reported in a Swedish patient with a hospitalization history in India, it exhibited resistant to all β-lactams except for monobactams, and has great potential to cause global health crisis (Yong et al., [@B46]). Initially, *bla*~NDM~ gene was endemic to India subcontinent and NDM-producing isolates tested worldwide have geographical links with these high prevalence areas. However, an increasing number of regions worldwide have reported that patients with *bla*~NDM−~positive isolates have never been abroad, indicating that *bla*~NDM~ genes are also associated with some special clones (Leverstein-Van et al., [@B20]).

In China, since the first report of *bla*~NDM~ gene in four carbapenem-resistant *Acinetobacter baumannii* isolates (Chen et al., [@B6]), increasing *Enterobacteriaceae* have been identified as carriers of the *bla*~NDM~ gene. *Escherichia coli*, an important member of *Enterobacteriaceae*, are often spread globally through some epidemiological lineages. Although the prevalence of NDM-producing CRE strains is low, outbreaks caused by *bla*~NDM~-positive isolates have been identified in several regions of China, indicating high transferability of the *bla*~NDM~ gene and the severity of infections caused by *bla*~NDM−1~-positive organisms (Wang et al., [@B41]; Jin et al., [@B14]; Yu et al., [@B47]). Furthermore, Kaase et al. ([@B16]) first reported a novel *bla*~NDM~ variant, *bla*~NDM−2~, which differs by one amino acid substitution (Pro28Ala) from *bla*~NDM−1~, and the subsequent discovery of other *bla*~NDM~ variants highlights the rapid evolution of this multi-drug resistance gene. In 2012, the NDM enzyme reservoir, India, first reported diverse *bla*~NDM~ variants among *Enterobacteriaceae* and *bla*~NDM~ variants exhibited higher minimum inhibitory concentration (MIC) levels of carbapenem compared with *bla*~NDM−1~ (Rahman et al., [@B32]). Although the *bla*~NDM~ gene is continuously recoverable in China, data on the prevalence and characteristics of *bla*~NDM~ variants among *Enterobacteriaceae* are still needed for preventing its transmission. Notably, a study conducted by Hu et al. ([@B13]) have discovered that various species of bacteria harbored several kinds of *bla*~NDM~ variants in China, which were mainly carried by diverse plasmids with different sizes. In the present study, we reported a high prevalence of *bla*~NDM~ variants among *E. coli* from five hospitals in Northern Jiangsu Province, China. Moreover, these diverse *bla*~NDM~ variants were mainly located on the same plasmid.

Materials and methods {#s2}
=====================

Study design
------------

From September 2015 to July 2016, five hospitals (two in Xuzhou, two in Suqian, and one in Lianyungang) in Northern Jiangsu Province of China collected 1,185 *E. coli* isolates to examine the prevalence and molecular epidemiology of carbapenem-resistance isolates. Initial species identification and antimicrobial susceptibility testing was performed by the Vitek 2 system (bioMe\'rieux, France) and MALDI-TOF MS (Bruker Microflex LT, Bruker Daltonik GmbH, Bremen, Germany) according to the manufacturer\'s instructions.

Antimicrobial susceptibility testing
------------------------------------

Initial susceptibility testing was examined by Vitek 2 system. Further MICtesting was conducted by agar dilution method for cefoxitin, ceftriaxone, ceftazidime, cefepime, aztreonam, amikacin, ciprofloxacin, tigecycline, and piperacillin/tazobactam. The MICs of imipenem, meropenem, and ertapenem were determined by E-tests. For colistin, MIC values were tested by broth microdilution method. The agar dilution method and E-test were performed according to the standard Clinical and Laboratory Standards Institute guideline (M100-S26) (CLSI, [@B7]). The breakpoints of Food and Drug Administration (FDA) and European Committee on Antimicrobial Susceptibility Testing were used for tigecycline and polymyxin, respectively.

Molecular detection of resistance genes
---------------------------------------

DNA templates were prepared by alkaline lysis method using the kit (MoBio, USA). Carbapenemase genes (*bla*~KPC~ *bla*~NDM~, *bla*~SME~*, bla*~GES~*,bla*~VIM~*, bla*~IMP~, and *bla*~OXA−48~) (Senda et al., [@B34]; Queenan et al., [@B30]; Poirel et al., [@B29]; Endimiani et al., [@B9]; Yang et al., [@B44]; Pereira et al., [@B27]; Al-Agamy et al., [@B1]), extended spectrumβ-lactamase genes (*bla*~SHV~*, bla*~TEM~*, bla*~CTX−M−1group~*, bla*~CTX−M−2group~*, bla*~CTX−M−8group~, and *bla*~CTX−M−9group~) (Schmitt et al., [@B33]; Yu et al., [@B48]), and plasmid-mediated AmpC genes(*bla*~ACC~*, bla*~FOX~*, bla*~MOX~*, bla*~DHA~*, bla*~CIT/SPM~, and *bla*~EBC~) (Pérez-Pérez and Hanson, [@B28]) were examined by PCR. *E. coli* ATCC25922 was used for the quality control. Positive amplifications were subject to Sanger sequencing (GENEWIZ Company, Suzhou, China).

PFGE and MLST
-------------

Molecular typing of 54 NDM-producing *E. coli* isolates was performed by pulsed-field gel electrophoresis (PFGE). The plugs containing genomic DNA were prepared according to the procedure described by Pereira et al. ([@B27]). The DNA fragments digested with restriction endonuclease *XbaI* (TaKaRa Biotechnology, Dalian, China) were separated by PFGE on 1% SeaKem Gold agarose (Lonza, Rockland, ME, USA) using the CHEF Mapper XA PFGE system (Bio-Rad, USA) for 18 h at 14°C. The electrophoretic switch times were 6.8--35.4 s. *Salmonella* H9812 was used as reference marker. Dice coefficients was used to calculate the similarity of PFGE patterns. Dendrograms were constructed by the unweighted pair group method with arithmetic averages (UPGMA) using BioNumerics software version 5.10. Isolates were categorized to be of the same cluster when their dice similarity index was ≥85%. Multi-locus sequence typing of *E. coli* was conducted by PCR as previously described (Wirth et al., [@B42]). The allelic profiles and sequence types were identified by amplifying and sequencing the seven housekeeping genes (*adk, fumC, gyrB, icd, mdh, purA, recA*) according to the reference website (<https://enterobase.warwick.ac.uk/species/index/ecoli>). A minimum spanning tree of 54 *bla*~NDM~-positive isolates was also constructed by BioNumerics software version 5.10.

Conjugation assay
-----------------

The conjugation experiment was implemented by mix broth mating among 26 selected isolates. The donor (clinical strains harboring the *bla*~NDM~ gene) and recipient (sodium azide-resistant *E. coli* J53) were mixed and cultured in broth at 37°C overnight. The transconjugants were selected on MH agar with sodium-azide (180 μg/mL) and imipenem (1 μg/mL). Initial species identification was conducted by Vitek MS system. Transformants were regarded as transconjugants when it exhibited resistance to carbapenem and harbored the *bla*~NDM~ gene.

Plasmid analysis
----------------

Twenty-six selected isolates, including *bla*~NDM~-~5~ and *bla*~NDM~-~1~ gene with different STs from the aforementioned five different hospitals and all *bla*~NDM~-~4~ (one isolates was lost in transit), *bla*~NDM~-~7~, and *bla*~NDM~-~9~-positive isolates, were subjected to further plasmid analysis. Incompatibility groups of plasmids extracted from transconjugants were determined by PCR-based replicon typing as described previously (Carattoli et al., [@B4]; Johnson et al., [@B15]). S1-PFGE and Southern blotting were conducted to isolate and locate resistance plasmids. Briefly, the gel plugs embedded with *bla*~NDM~-positive isolates were digested with S1 nuclease (TaKaRa Biotechnology, Dalian, China) and linear plasmids were separated by CHEF-Mapper XA PFGE system (Bio-Rad) as described above. The universal primers (F: GAAGCTGAGCACCGCATTAG; R: GGGCCGTATGAGTGATTGC) were used for probe synthesis. The plasmid DNA were transferred to positive-charged nylon membranes (Millipore, USA), and DIG-labeled *bla*~NDM−~specific probe served to hybridize plasmids according to the instructions of the DIG High Prime DNA Labeling and Detection Starter Kit (Roche, USA).

Results {#s3}
=======

Clinical data and prevalence of carbapenemase genes among CRECO
---------------------------------------------------------------

A total of 54 (4.56%, 54/1185) non-duplicate *E. coli* isolates that exhibited resistance to imipenem or meropenem were obtained from five hospitals in Northern Jiangsu Province, China. The Affiliated Hospital of Xuzhou Medical University (Hosptial A, *n* = 18), the Children\'s Hospital of Xuzhou (Hosptial B, *n* = 13), the People\'s Hospital of Suqian (Hosptial C, *n* = 11), the First People\'s Hospital of Suqian (Hosptial D, *n* = 6), and the Second People\'s Hospital of Lianyungang (Hosptial E, *n* = 6) were included. Among 54 CRECO isolates, 53 (98.1%, 53/54) were found to be *bla*~NDM~-positive and 1 was *bla*~KPC−2~-positive. Interestingly, five different *bla*~NDM~ variants were identified in this collection (Figure [1](#F1){ref-type="fig"}). Among them, the *bla*~NDM−5~ was the prevailing variant, accounting for 58.5% (31/53) of *bla*~NDM~-positive isolates, followed by *bla*~NDM−1~ (26.4%, 14/53). Moreover, *bla*~NDM−7~, *bla*~NDM−4~, and *bla*~NDM−9~ genes were also identified in 5, 2, and 1 isolates, respectively. NDM variations in amino acid substitutions at various positions are shown in Table [1](#T1){ref-type="table"}. The distribution of the *bla*~NDM~ variants in hospitals is depicted in Figure [1](#F1){ref-type="fig"}.

![The distribution of *bla*~NDM~ variants among different hospitals. Hospital A, the Affiliated Hospital of Xuzhou Medical University; Hospital B, the Children\'s Hospital of Xuzhou; Hospital C, the People\'s Hospital of Suqian; Hospital D, the First People\'s Hospital of Suqian; Hospital E, the Second People\'s Hospital of Lianyungang.](fmicb-09-02704-g0001){#F1}

###### 

Amino acid substitutions of initially reported NDM variants.

  **NDM-type**   **Val 88**   **Asp 130**   **Glu 152**   **Met 154**   **Isolates**               **Country**   **Tourism history**   **GenBank accession no**.
  -------------- ------------ ------------- ------------- ------------- -------------------------- ------------- --------------------- ---------------------------
  NDM-1          --           --            --            --            *K. pneumoniae, E. coli*   Sweden        India                 [FN396876](FN396876)
  NDM-4          --           --            --            Leu           *E. coli*                  Cameroon      Pakistan              [JQ348841](JQ348841)
  NDM-5          Leu          --            --            Leu           *E. coli*                  UK            India                 [JN104597](JN104597)
  NDM-7          --           Asn           --            Leu           *E. coli*                  UK            Spain                 [JX262694](JX262694)
  NDM-9          --           --            Lys           --            *K. pneumoniae*            China         No                    [KC999080](KC999080)

Antimicrobial susceptibility patterns and prevalence of additional resistance genes of NDM-producing CRECO
----------------------------------------------------------------------------------------------------------

Fifty-three NDM-producing CRECO isolates were resistant to all cephalosporins (cefoxitin, ceftriaxone, ceftazidime, and cefepime) and enzyme inhibitors (piperacillin/tazobactam) but remained susceptible to colistin and tigecycline. The resistance rates to aztreonam, amikacin, and ciprofloxacin were 84.9, 22.6, and 92.4%, respectively. As shown in Table [2](#T2){ref-type="table"}, among 31 *bla*~NDM−5~-positive isolates, 93.5% were resistant to ciprofloxacin, 74.2% to aztreonam, and 32.2% to amikacin. Resistance to aztreonam and ciprofloxacin were 85.7 and 92.9% among 14 *bla*~NDM−1~-producing isolates and were susceptible to amikacin. As for *bla*~NDM−7~-positive isolates, susceptibility was only found for amikacin. The *bla*~NDM−4~ and *bla*~NDM−9~ isolates were resistant to all antibiotics tested in this study except for colistin and tigecycline. One *bla*~KPC−2~-positive isolate was resistant to amikacin, colistin, and tigecycline. Molecular features revealed that most CRECO isolates carried the ESBLs gene, AmpC gene, or both. Overall, *bla*~CTX−M~*, bla*~SHV~, and *bla*~TEM~ were identified in 42, 11, and 32 isolates, respectively. *bla*~CTX−M~-~15~ was the most common ESBLs gene in our study, accounting for 26.4% followed by *bla*~CTX−M~-~55~ (*n* = 9), *bla*~CTX−M~-~65~ (*n* = 8), *bla*~CTX−M~-~14~ (*n* = 8). *bla*~CTX−M~-~64~ (*n* = 1), *bla*~CTX−M~-~90~ (*n* = 1), and *bla*~CTX−M~-~123~ (*n* = 1). All *bla*~TEM~ positive isolates were identified as *bla*~TEM−1~. Moreover, 6 *bla*~CMY−2~, 5 *bla*~CMY−42~, and 1 *bla*~DHA−1~ were also identified.

###### 

Antimicrobial susceptible patterns of NDM-producing *Escherichia coli*.

  **Antibotic**   **Total (*****n*** = **53)**   **NDM-5 (*****n*** = **31)**   **NDM-1 (*****n*** = **14)**   **NDM-7 (*****n*** = **5)**   **NDM-4 (*****n*** = **2)**   **NDM-9 (*****n*** = **1)**                                           
  --------------- ------------------------------ ------------------------------ ------------------------------ ----------------------------- ----------------------------- ----------------------------- ------- ------- ------- ------- ------- -------
  IMP             0.0                            100.0                          0.0                            100.0                         0.0                           100.0                         0.0     100.0   0.0     100.0   0.0     100.0
  MEP             0.0                            100.0                          0.0                            100.0                         0.0                           100.0                         0.0     100.0   0.0     100.0   0.0     100.0
  ETP             0.0                            100.0                          0.0                            100.0                         0.0                           100.0                         0.0     100.0   0.0     100.0   0.0     100.0
  FOX             0.0                            100.0                          0.0                            100.0                         0.0                           100.0                         0.0     100.0   0.0     100.0   0.0     100.0
  CRO             0.0                            100.0                          0.0                            100.0                         0.0                           100.0                         0.0     100.0   0.0     100.0   0.0     100.0
  CAZ             0.0                            100.0                          0.0                            100.0                         0.0                           100.0                         0.0     100.0   0.0     100.0   0.0     100.0
  FEP             0.0                            100.0                          0.0                            100.0                         0.0                           100.0                         0.0     100.0   0.0     100.0   0.0     100.0
  ATM             15.1                           81.1                           22.6                           74.2                          7.1                           85.7                          0.0     100.0   0.0     100.0   0.0     100.0
  AMK             75.4                           22.6                           67.7                           32.2                          92.9                          0.0                           60.0    40.0    0.0     100.0   0.0     100.0
  CIP             5.7                            92.4                           6.5                            93.5                          7.1                           92.9                          0.0     80.0    0.0     100.0   0.0     100.0
  TZP             0.0                            100.0                          0.0                            100.0                         0.0                           100.0                         0.0     100.0   0.0     100.0   0.0     100.0
  TGC             100.0                          0.0                            100.0                          0.0                           100.0                         0.0                           100.0   0.0     100.0   0.0     100.0   0.0
  COL             100.0                          0.0                            100.0                          0.0                           100.0                         0.0                           100.0   0.0     100.0   0.0     100.0   0.0

*IMP, imipenem; ETP, ertapenem; MEP, meropenem; PB, colistin; TGC, tigecycline; ATM, aztreonam; FOX, cefoxitin; FEP, cefepime; CA, ceftazidim; CRO, cefatriaxone; YZP, piperacillin/tazobactam; AMK, amikacin; CIP, ciprofloxacin*.

Molecular typing of CRECO
-------------------------

A total of 15 STs were identified in 54 CRECO isolates (Figure [2](#F2){ref-type="fig"}). Among 53 *bla*~NDM~-producing isolates, ST167 was the most prevalent, accounting for 35.8% (19/53), followed by ST410 (16.9%, 9/53), ST617 (13.2%, 7/53), ST405 (5.6%, 3/53), ST155 (3.8%, 2/53), ST156 (3.8%, 2/53), ST361 (3.8%, 2/53), and ST2659 (3.8%, 2/53). ST90, ST224, ST46, ST648, ST2376, and ST2083 were identified in one isolate. ST167 and ST617 are different by one allele and both correspond to clonal complex CC10. Moreover, ST410 and ST90 belong to clonal complex CC23. One KPC-2-producing isolate belong to ST131. PFGE typing revealed that no more than two isolates with the same ST type appeared to the same band pattern except for three ST410 isolates from hospital B (Figure [3](#F3){ref-type="fig"}). Surprisingly, the two isolates (E11 and E28) from hospital A and B shared the same patterns, indicating the occurrence of cross-transmission between hospitals.

![Minimum spanning tree of 54 CRECO isolates from different hospitals.](fmicb-09-02704-g0002){#F2}

![Dendrogram of PFGE profiles of 54 CRECO isolates. The UPGMA algorithm was used to construct dendrogram based on the dice similarity coefficient. Isolates were categorized to be of the same cluster when their dice similarity index was ≥ 85%.](fmicb-09-02704-g0003){#F3}

Characteristic of plasmids harboring the *bla*~NDM~ gene
--------------------------------------------------------

All of plasmids haboring *bla*~NDM~ gene from 26 selected CRECO isolates were successfully transferred to *E. coli* J53, and transconjugants exhibited resistance to carbapenem, cephalosporins and enzyme inhibitors (Table [3](#T3){ref-type="table"}). As shown in Figure [4](#F4){ref-type="fig"}, S1-PFGE and Southern blotting revealed that all *bla*~NDM−5~ genes were located on the same size (\~55 kb) plasmids, which was associated with IncX3 (*n* = 5), IncFI (*n* = 3), IncFII (*n* = 1), and untypeable replicon (*n* = 3). The *bla*~NDM−1~ genes were carried by 55\~210 kb plasmids, including IncX3 (*n* = 5), IncFI (*n* = 1), and IncFII (*n* = 1) replicon types. Among five *bla*~NDM−7~ positive isolates, four harbored \~55 kb IncX3 plasmids with DIG-labeled *bla*~NDM−7~, and the remaining one was carried by \~110 kb IncFI plasmid. The *bla*~NDM−4~ and *bla*~NDM−9~ genes were located on \~55 kb IncX3 and \~110 kb IncI1 plasmids, respectively. Surprisingly, E5 isolates harbored three *bla*~NDM−5−~positive plasmids of \~55, \~105, and \~320 kb in size, suggesting high insertion efficiency of the *bla*~NDM~ gene. Further plasmid sequencing from E5 isolates revealed that the respective GenBank accession numbers for \~55 and \~105 kb plasmids were [NC_022740.1](NC_022740.1) and [AP018144.1](AP018144.1), however, the nucleotide sequences of \~320 kb plasmid could not be completely obtained.

###### 

Antimicrobial susceptible patterns and characteristics of 26 selected NDM-producing *Escherichia coli* (μg/mL).

  **Isolates**                              **Antimicrobial susceptible**                       **Hospital**   **Carbapenemase**   **MLST**   **Imp and size (kb)**                                                   
  -------------- --------- ------ --------- ------------------------------- --------- --------- -------------- ------------------- ---------- ----------------------- ------- ------- ---------- --- ------- -------- ---------------------------------------------------------------------------------------
  E5             \>32      32     \>32      \>256                           \>256     \>256     \>256          \>256               \>256      32                      \>256   0.5     0.5        A   NDM-5   ST167    X3/55[^a^](#TN1){ref-type="table-fn"}, FII/105[^b^](#TN2){ref-type="table-fn"},UT/320
  E5-J53         8         2      4         \>256                           \>256     \>256     16             64                  0.5        ≤ 0.06                  256     0.25    0.25                            
  E7             8         8      4         \>256                           256       \>256     32             16                  \>256      64                      128     0.25    0.5        A   NDM-5   ST224    FII/55
  E7-J53         4         2      4         \>256                           256       \>256     8              16                  1          ≤ 0.06                  128     0.125   0.25                            
  E12            16        8      4         \>256                           \>256     \>256     256            2                   2          128                     \>256   0.5     0.25       A   NDM-5   ST410    UT/55
  E12-J53        8         4      8         \>256                           \>256     \>256     32             2                   0.5        ≤ 0.06                  256     0.5     0.25                            
  E22            \>32      24     \>32      \>256                           \>256     \>256     \>256          4                   2          64                      \>256   0.5     1          B   NDM-5   ST617    X3/55
  E22-J53        8         2      6         \>256                           \>256     \>256     32             1                   1          ≤ 0.06                  \>256   0.25    0.5                             
  E21            \>32      12     \>32      \>256                           \>256     \>256     128            \>256               4          1                       \>256   0.5     0.5        B   NDM-5   ST155    X3/55
  E21-J53        16        6      8         \>256                           \>256     \>256     16             32                  2          ≤ 0.06                  256     0.5     0.25                            
  E28            \>32      \>32   \>32      \>256                           \>256     \>256     \>256          \>256               128        64                      256     0.5     0.5        B   NDM-5   ST167    X3/55
  E28-J53        16        4      8         \>256                           \>256     \>256     32             16                  0.5        ≤ 0.06                  256     0.125   0.5                             
  E36            \>32      \>32   \>32      \>256                           \>256     \>256     256            1                   4          64                      \>256   0.25    0.25       C   NDM-5   ST2659   FI/55
  E36-J53        8         2      4         \>256                           \>256     \>256     64             2                   1          ≤ 0.06                  \>256   0.25    \< 0.125                        
  E37            \>32      \>32   \>32      \>256                           \>256     \>256     256            1                   2          128                     \>256   0.5     1          C   NDM-5   ST156    X3/55
  E37-J53        8         2      4         \>256                           \>256     \>256     32             2                   1          ≤ 0.06                  256     0.25    0.25                            
  E49            \>32      \>32   \>32      \>256                           \>256     \>256     \>256          \>256               2          256                     \>256   0.125   0.5        D   NDM-5   ST167    X3/55
  E49-J53        16        6      8         \>256                           \>256     \>256     32             128                 0.5        ≤ 0.06                  \>256   0.125   0.5                             
  E33            \>32      \>32   \>32      \>256                           \>256     \>256     256            \>256               \>256      128                     128     0.5     0.5        D   NDM-5   ST405    FI/55
  E33-J53        4         2      2         \>256                           \>256     \>256     16             1                   32         ≤ 0.06                  \>256   0.25    0.125                           
  E47            \>32      \>32   \>32      \>256                           \>256     \>256     256            4                   8          8                       \>256   0.25    0.5        E   NDM-5   ST410    UT/55
  E47-J53        8         4      6         \>256                           \>256     \>256     16             2                   0.5        ≤ 0.06                  \>256   0.25    0.5                             
  E48            \>32      \>32   \>32      \>256                           \>256     \>256     256            4                   4          128                     \>256   0.5     0.5        E   NDM-5   ST2083   FI/55
  E48-J53        4         2      3         \>256                           \>256     \>256     16             1                   0.5        ≤ 0.06                  \>256   0.125   0.5                             
  E15            \>32      8      8         \>256                           \>256     \>256     \>256          \>256               2          64                      \>256   0.25    0.25       A   NDM-1   ST167    FII/210
  E15-J53        8         4      4         \>256                           \>256     \>256     32             2                   0.25       ≤ 0.06                  \>256   0.25    \< 0.125                        
  E3             32        4      8         \>256                           \>256     \>256     128            256                 4          64                      \>256   0.25    0.125      A   NDM-1   ST405    X3/55
  E3-J53         12        4      4         \>256                           \>256     \>256     16             \>256               2          ≤ 0.06                  \>256   0.25    \< 0.125                        
  E20            \>32      \>32   \>32      \>256                           \>256     \>256     128            256                 2          256                     \>256   0.25    0.5        B   NDM-1   ST410    X3/55
  E20-J53        8         4      4         \>256                           \>256     \>256     128            256                 0.25       ≤ 0.06                  \>256   0.25    0.125                           
  E8             \>32      8      8         \>256                           \>256     \>256     \>256          256                 2          128                     \>256   0.5     0.5        B   NDM-1   ST167    X3/210
  E8-J53         16        4      8         \>256                           \>256     \>256     16             256                 1          ≤ 0.06                  \>256   0.5     0.25                            
  E44            \>32      12     12        \>256                           \>256     \>256     64             1                   2          256                     128     0.125   0.25       C   NDM-1   ST167    X3/170
  E44-J53        16        2      4         \>256                           \>256     \>256     32             \>256               0.5        ≤ 0.06                  128     0.125   0.25                            
  E32            \>32      \>32   \>32      \>256                           \>256     \>256     256            256                 4          256                     \>256   0.5     1          D   NDM-1   ST167    FI/55
  E32-J53        8         2      4         \>256                           \>256     \>256     16             2                   0.5        ≤ 0.06                  256     0.125   0.125                           
  E53            16        8      6         \>256                           \>256     \>256     64             256                 2          1                       128     0.5     0.5        D   NDM-1   ST2376   X3/55
  E53-J53        8         4      6         \>256                           \>256     \>256     16             1                   0.25       ≤ 0.06                  128     0.5     0.25                            
  E6             16        8      8         \>256                           \>256     \>256     \>256          \>256               \>256      64                      \>256   0.5     1          A   NDM-9   ST156    I1/105
  E6-J53         6         2      2         \>256                           \>256     \>256     32             64                  2          ≤ 0.06                  256     0.125   0.25                            
  E16            16        8      8         \>256                           \>256     \>256     128            \>256               1          32                      \>256   0.25    0.25       A   NDM-4   ST410    X3/55
  E16-J53        4         2      2         \>256                           \>256     \>256     16             1                   0.5        ≤ 0.06                  \>256   0.25    0.25                            
  E38            \>32      \>32   \>32      \>256                           \>256     \>256     \>256          \>256               4          256                     \>256   0.125   0.5        C   NDM-7   ST410    FI/110
  E38-J53        8         2      4         \>256                           \>256     \>256     16             4                   2          ≤ 0.06                  256     0.125   0.125                           
  E39            \>32      \>32   \>32      \>256                           \>256     \>256     256            \>256               2          1                       \>256   0.5     0.5        C   NDM-7   ST167    X3/55
  E39-J53        16        6      8         \>256                           \>256     \>256     32             128                 1          ≤ 0.06                  256     0.25    0.25                            
  E41            \>32      \>32   \>32      \>256                           \>256     \>256     256            \>256               2          256                     \>256   0.25    1          C   NDM-7   ST2659   X3/55
  E41-J53        8         4      6         \>256                           \>256     \>256     16             2                   1          ≤ 0.06                  \>256   0.25    0.25                            
  E45            \>32      24     \>32      \>256                           \>256     \>256     256            \>256               \>256      64                      \>256   0.5     0.5        E   NDM-7   ST617    X3/55
  E45-J53        16        4      8         \>256                           \>256     \>256     16             256                 2          ≤ 0.06                  \>256   0.125   \< 0.125                        
  E46            \>32      12     \>32      \>256                           \>256     \>256     \>256          \>256               \>256      128                     \>256   0.5     0.25       E   NDM-7   ST617    X3/55
  E46-J53        8         4      6         \>256                           \>256     \>256     16             64                  0.5        ≤ 0.06                  \>256   0.5     0.125                           
  E.coli J53     ≤ 0.125   0.25   ≤ 0.125   4                               ≤ 0.125   ≤ 0.125   ≤ 0.125        ≤ 0.125             ≤ 0.125    ≤ 0.125                 2       0.125   \< 0.125                        

IMP, imipenem; ETP, ertapenem; MEP, meropenem; PB, colistin; TGC, tigecycline; ATM, aztreonam; FOX, cefoxitin; FEP, cefepime; CAZ, ceftazidim; CRO, cefatriaxone; YZP, piperacillin/tazobactam; AMK, amikacin; CIP, ciprofloxacina: a

*GenBank accession no. [NC_022740.1](NC_022740.1)*;

*GenBank accession no. [AP018144.1](AP018144.1)*.

![Isolation and determination of plasmids harboring the *bla*~NDM~ gene in 26 clinical and transconjugants (**Top**: S1-nuclease PFGE patterns; **Bottom**: Southern blotting with a *bla*~NDM~ specific probe). The arrows represent thelocation of linear plasmid DNA hybridized with the *bla*~NDM~ specific probe. M: Braenderup H9812 Marker; lane 1: E5; lane 2: E7; lane 3: E12; lane4: E22; lane 5: E21; lane 6: E28; lane 7: E36; lane 8: E37; lane 9: E49; lane 10: E33; lane 11: E47; lane 12: E48; lane 13: E15; lane 14: E3; lane 15: E20; lane 16: E8; lane 17: E44; lane18: E32; lane 19: E53; lane 20: E6; lane 21: E16; lane 22: E38; lane 23: E39; lane 24: E41; lane 25: E45; lane 26: E46.](fmicb-09-02704-g0004){#F4}

Discussion {#s4}
==========

Metallo-lactamase, NDM, is an emerging carbapenem-resistant β-lactamase that is of major public concern due to its high medical and economic burden (Otter et al., [@B26]), especially for developing countries such as India, Pakistan, and the Balkan countries. As the most populous country in the world, there are major difficulties in preventing the dissemination of multidrug resistant genes in China. Therefore, comprehensive, extensive studies on diverse *bla*~NDM~ variant-positive *E. coli* are needed to provide clear information to optimize antibiotic policy in endemic areas.

Generally, the prevalence of the *bla*~NDM~ gene has continuously increased worldwide. As of now, the NDM enzyme has been identified in almost all of the world, including many countries in Asia, Africa, Europe, the Americas, and Australia (Berrazeg et al., [@B3]). A study from India also analyzed the occurrence of the *bla*~NDM~ gene among carbapenem resistant isolates, and it accounted for 45.4% of them (Rahman et al., [@B31]). Recently, a survey from the French National Reference Center revealed that among 140 carbapenem-resistant isolates 21% were NDM producer (Gauthier et al., [@B10]). In 2017, a nationwide study of clinical CRE strains in China demonstrated that 49% were NDM producer among carbapenem-resistant *E. coli* (Zhang et al., [@B50]). Furthermore, a multicenter study of the China CRE network revealed that among 39 carbapenem-resistant *E. coli* isolates, 74.4% were NDM producer, suggesting that there is a serious challenge in combating infections caused by this "superbug" in China (Zhang et al., [@B51]). In the present study, we identified 53 *bla*~NDM~-carrying isolates among 54 CRECO, which is much higher than in any other region of China (Wang S. et al., [@B40]; Hu et al., [@B13]; Liang et al., [@B22]). To the best of our knowledge, this is also the first report on the *bla*~NDM~ gene in Northern Jiangsu Province. Moreover, the emergence of such a high prevalence of *bla*~NDM~ variants indicates that the *bla*~NDM~ gene is increasing in this area.

Since its first identification in 2009, the *bl*a~NDM~ gene has evolved at a fast pace during the past 10 years. Twenty-one *bla*~NDM~ variants have been identified in different countries, all of which are archived at <http://www.lahey.org/Studies/other.asp>. Khan et al. ([@B17]) reported that the Asian continent, especially China and India, was a reservoir of NDM producers, in which about a 58.2% abundance of the *bla*~NDM−1~ variants was found. Among these *bla*~NDM~ variants, the *bla*~NDM−1~ gene has been reported as the most prevalent type worldwide (Nordmann and Poirel, [@B25]). In our study, five *bla*~NDM~ variants were identified as responsible for MBL production, with the *bla*~NDM−5~ gene being the most prevalent. Compared with NDM-1, NDM-5 producers exhibited higher hydrolytic activity and toxicity toward carbapenem and cephalosporin (Mei et al., [@B24]). The *bla*~NDM−5~ gene is an emerging *bla*~NDM~ variants and has tended to surpass *bla*~NDM−1~ recently, and it differs from the NDM-1 enzyme at two amino acid substitutions, exhibited increased carbapenem resistance (Zhang et al., [@B49]). The *bla*~NDM−4~ and *bla*~NDM−7~ genes have been discovered among *E. coli* in China with relatively low prevalence, involving in 4 and 6 patients, respectively. Moreover, clinical *bla*~NDM−9~-positive *E. coli* has only been found in Taiwan (Lai et al., [@B19]), with this being the first report on the mainland China. Moreover, not merely NDM-5, amino acid substitutions in NDM-4 (M154L), NDM-7 (D130A), and NDM-9 (E152A) could also result in high levels of carbapenem resistance (Düzgün, [@B8]). Stewart et al. ([@B35]) reported that the substitution in M154L, which is found in most *bla*~NDM~ variants, could enhance resistance to ampicillin at low zinc(II) concentrations relevant to infection sites.

*bla*~NDM~ variant-positive isolates exhibited multi-drug resistance. Variable resistances to aztreonam, amikacin, and ciprofloxacin were identified in NDM-1 and NDM-5-producing *E. coli*. The NDM-7, NDM-4, and NDM-9-producing isolates exhibited pan-resistant phenotypes, showing resistance to almost all commonly used clinical antibiotics except for colistin and tigecycline. In view of this, the expert recommended polymyxins was regarded as the last resort for NDM-producing isolates (Yamamoto and Pop-Vicas, [@B43]).

ST167 was confirmed as significant carrier in the present study, and is reported to be associated with the production of the NDM enzyme, especially NDM-5 (Chen et al., [@B5]). Notably, four *bla*~NDM~-positive ST617 strains were identified in the world, but we identified 6 isolates in the present study. Moreover, a novel new variant of *bla*~NDM~, *bla*~NDM−21~, belonged to ST617, which should deserve more attention (Liu et al., [@B23]). Furthermore, four new STs ST361, ST46, ST2376, and ST2083 were firstly reported to be linked with NDM-producing isolates.

The high efficiency of transfer renders the NDM producer ubiquitous throughout the world. Torres-González et al. ([@B36]) reported an outbreak caused by *bla*~NDM−1~-carrying plasmid, which is easily transferred between *E. coli* and *Klebsiella pneumoniae*. Similarly, in the present study, the plasmids of 26 selected CRECO isolates were also tested for transfer. All selected *bla*~NDM−5~ genes were identified to be located on 55 kb plasmid, among which IncX3 was the most common replicon type. Notably, *bla*~NDM−5~ gene was frequently reported to be carried by the IncX3 plasmid of 55 kb in size, which was widely reported in China (Yang et al., [@B45]), Inidia (Krishnaraju et al., [@B18]), Australia (Wailan et al., [@B37]), and Damark (Hammerum et al., [@B12]). Moreover, Li et al. ([@B21]) reported that IncX3 type plasmids play an important role in the transmission of the *bla*~NDM−5~ gene in *Enterobacteriaceae* and this kind of plasmid occurred in different species. Further illustrated the challenge of preventing the dissemination of the *bla*~NDM−5~ gene. The widespread *bla*~NDM−1~-carrying plasmid has been found to be associated with multiple replicon types, including IncX3, IncF, and IncA/C etc. In agreement with previous studies (Göttig et al., [@B11]; Wang L. H. et al., [@B39]), four *bla*~NDM−7~-positive plasmids were identified as \~55 kb IncX3 type, while the *bla*~NDM−7~ gene was also detected in the IncFI plasmid, which have been identified in India (Rahman et al., [@B32]). As for *bla*~NDM−9~, to the best of our knowledge, this is the first report on \~105 kb IncI1 type plasmid harboring *bla*~NDM−9~ gene. Overall, most plasmids harboring *bla*~NDM~ variants were identified as 55 kb IncX3 types, hinting that amino acid mutations might occur in the process of plasmid transfer, resulting in the emergence of *bla*~NDM~ variants. The high prevalence of the *bla*~NDM~ genes due in part to plasmid transfer, meanwhile, the fast evolution of this multidrug resistance gene also favors the persistence of such bacteria harboring it.

In summary, the present study reported high prevalence of *bla*~NDM~ variants, especially *bla*~NDM−5~, among carbapenem-resistant *E. coli* in Northern Jiangsu Province. The presence of five different variants further increases the threat to public health because of the limited treatment options. Notably, diverse *bla*~NDM~ variants were mainly located on \~55 kb IncX3 plasmids, indicating that the fast evolution and high transferability of this kind of plasmid has led to the high prevalence of *bla*~NDM~ variants. Timely detection of NDM enzyme and antimicrobial susceptibility testing are necessary so that infections caused by NDM producers receive appropriate and effective therapy. Similarly, large-scale surveillance and effective infection control measures are also urgently needed to prevent diverse *bla*~NDM~ variants from becoming epidemics in the future.
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